IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis
Article in Frontiers in Immunology (March 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (March 2024)
Article in Anti-Cancer Drugs (January 2024)
Article in Frontiers in Pharmacology (January 2024)